These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 11555904)

  • 1. [Becker muscular dystrophy].
    Ishihara T
    Ryoikibetsu Shokogun Shirizu; 2001; (35):18-22. PubMed ID: 11555904
    [No Abstract]   [Full Text] [Related]  

  • 2. [Duchenne muscular dystrophy].
    Ishihara T
    Ryoikibetsu Shokogun Shirizu; 2001; (35):14-7. PubMed ID: 11555892
    [No Abstract]   [Full Text] [Related]  

  • 3. Myodys, a full-length dystrophin plasmid vector for Duchenne and Becker muscular dystrophy gene therapy.
    Duan D
    Curr Opin Mol Ther; 2008 Feb; 10(1):86-94. PubMed ID: 18228186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of intermittent positive pressure ventilation on life-span and causes of death in Duchenne muscular dystrophy].
    Konagaya M; Sakai M; Wakayama T; Kimura S; Kuru S; Yasuma F
    Rinsho Shinkeigaku; 2005 Sep; 45(9):643-6. PubMed ID: 16248395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [18 years experience with mechanical ventilation in patients with Duchenne muscular dystrophy].
    Meinesz AF; Bladder G; Goorhuis JF; Fock JM; Staal-Schreinemachers AL; Zijlstra JG; Wijkstra PJ
    Ned Tijdschr Geneeskd; 2007 Aug; 151(33):1830-3. PubMed ID: 17874640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic strategies for Duchenne and Becker dystrophies.
    Voisin V; de la Porte S
    Int Rev Cytol; 2004; 240():1-30. PubMed ID: 15548414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duchenne and Becker muscular dystrophy: from gene diagnosis to molecular therapy.
    Matsuo M
    IUBMB Life; 2002 Mar; 53(3):147-52. PubMed ID: 12102170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proximal dystrophin gene deletions and protein alterations in becker muscular dystrophy.
    Novaković I; Bojić D; Todorović S; Apostolski S; Luković L; Stefanović D; Milasin J
    Ann N Y Acad Sci; 2005 Jun; 1048():406-10. PubMed ID: 16154963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modular flexibility of dystrophin: implications for gene therapy of Duchenne muscular dystrophy.
    Harper SQ; Hauser MA; DelloRusso C; Duan D; Crawford RW; Phelps SF; Harper HA; Robinson AS; Engelhardt JF; Brooks SV; Chamberlain JS
    Nat Med; 2002 Mar; 8(3):253-61. PubMed ID: 11875496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Don't stop me now!].
    Wolf A; Schaack J; Freikamp L; Reutzel S; Zündorf I; Dingermann T
    Pharm Unserer Zeit; 2008; 37(5):356-7. PubMed ID: 18729286
    [No Abstract]   [Full Text] [Related]  

  • 11. [The silent yet successful revolution of mechanical ventilation in patients with neuromuscular disorders, in particular Duchenne muscular dystrophy].
    van Engelen BG
    Ned Tijdschr Geneeskd; 2007 Aug; 151(33):1817-8. PubMed ID: 17874636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac monitoring and treatment for children and adolescents with neuromuscular disorders.
    Bourke JP
    Dev Med Child Neurol; 2006 Mar; 48(3):164. PubMed ID: 16483389
    [No Abstract]   [Full Text] [Related]  

  • 13. Splicing intervention for Duchenne muscular dystrophy.
    McClorey G; Fletcher S; Wilton S
    Curr Opin Pharmacol; 2005 Oct; 5(5):529-34. PubMed ID: 16085461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion analysis of the dystrophin gene in Duchenne and Becker muscular dystrophy patients: use in carrier diagnosis.
    Kumari D; Mital A; Gupta M; Goyle S
    Neurol India; 2003 Jun; 51(2):223-6. PubMed ID: 14571009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [From gene to disease; the dystrophin gene involved in Duchenne and Becker muscular dystrophy].
    den Dunnen JT; de Visser M; Bakker E
    Ned Tijdschr Geneeskd; 2002 Feb; 146(8):364-7. PubMed ID: 11887623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Duchenne muscular dystrophy: perspectives of treatment].
    Palmieri B; Sblendorio V
    Recenti Prog Med; 2006 Sep; 97(9):448-58. PubMed ID: 17017294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shrinking genes for therapy.
    Bonetta L
    Nat Med; 2002 Mar; 8(3):222. PubMed ID: 11875490
    [No Abstract]   [Full Text] [Related]  

  • 18. Dystrophin analysis in carriers of Duchenne and Becker muscular dystrophy.
    Hoogerwaard EM; Ginjaar IB; Bakker E; de Visser M
    Neurology; 2005 Dec; 65(12):1984-6. PubMed ID: 16380627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of therapy for Duchenne muscular dystrophy.
    Zhang S; Xie H; Zhou G; Yang Z
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Feb; 21(2):194-203. PubMed ID: 17357471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DMD pseudoexon mutations: splicing efficiency, phenotype, and potential therapy.
    Gurvich OL; Tuohy TM; Howard MT; Finkel RS; Medne L; Anderson CB; Weiss RB; Wilton SD; Flanigan KM
    Ann Neurol; 2008 Jan; 63(1):81-9. PubMed ID: 18059005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.